îæ€çŽ¢
îæ€çŽ¢
î
BCPE Perseus Investor Ord Shs (Proposed)
KLRAîãŠã©ãããªã¹ãã«è¿œå
12.390USD
-0.740-5.64%
ååŒæé 09/24, 09:36ïŒETïŒ
1.61Bæ䟡ç·é¡
0.00çŽè¿12ã¶æPER
BCPE Perseus Investor Ord Shs (Proposed)ã«ã€ã㊠äŒæ¥å
Kailera Therapeutics Inc is a United States-based company. The Company is a clinical-stage biopharmaceutical company developing a broad and advanced therapeutic pipeline that is poised to deliver differentiated treatment options for obesity and related conditions. Its pipeline consists of clinical- and preclinical-stage programs with injectable peptides, oral peptides, and an oral small molecule.
BCPE Perseus Investor Ord Shs (Proposed) ãããã£ãŒã«
îäŒæ¥ã³ãŒãKLRA
äŒç€ŸåKailera Therapeutics Inc
äžå Žæ¥Apr 17, 2026
æé«çµå¶è²¬ä»»è
ãCEOãRenaud (Ron)
åŸæ¥å¡æ°- -
蚌åžçš®é¡Ordinary Share
決ç®ææ«- -
æ¬ç€Ÿæåšå°180 Third Ave
éœåžWALTHAM
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·02451
é»è©±çªå·15084409475
ãŠã§ããµã€ãhttps://www.kailera.com
äŒæ¥ã³ãŒãKLRA
äžå Žæ¥Apr 17, 2026
æé«çµå¶è²¬ä»»è
ãCEOãRenaud (Ron)
BCPE Perseus Investor Ord Shs (Proposed)ã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Mr. Ronald C. (Ron) Renaud, Jr.
Mr. Ronald C. (Ron) Renaud, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Paul Burgess, J.D.
Mr. Paul Burgess, J.D.
Chief Operating Officer, Chief Business Officer
Chief Operating Officer, Chief Business Officer
--
--
Ms. Paula Cloghessy
Ms. Paula Cloghessy
Chief People Officer
Chief People Officer
--
--
Mr. Scott M. Akamine, J.D.
Mr. Scott M. Akamine, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
--
--
Ms. Jamie Coleman
Ms. Jamie Coleman
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Douglas W. Pagan
Mr. Douglas W. Pagan
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Scott Wasserman, M.D.
Dr. Scott Wasserman, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Franklin K. (Frank) Clyburn, Jr.
Mr. Franklin K. (Frank) Clyburn, Jr.
Independent Director
Independent Director
--
--
Mr. Christopher D. (Chris) Hite, J.D.
Mr. Christopher D. (Chris) Hite, J.D.
Independent Director
Independent Director
--
--
詳现ãèŠã
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Mr. Ronald C. (Ron) Renaud, Jr.
Mr. Ronald C. (Ron) Renaud, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Paul Burgess, J.D.
Mr. Paul Burgess, J.D.
Chief Operating Officer, Chief Business Officer
Chief Operating Officer, Chief Business Officer
--
--
Ms. Paula Cloghessy
Ms. Paula Cloghessy
Chief People Officer
Chief People Officer
--
--
Mr. Scott M. Akamine, J.D.
Mr. Scott M. Akamine, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
--
--
Ms. Jamie Coleman
Ms. Jamie Coleman
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Douglas W. Pagan
Mr. Douglas W. Pagan
Chief Financial Officer
Chief Financial Officer
--
--
ãããã質å
BCPE Perseus Investor Ord Shs (Proposed)ã®äžäœ5åã®æ ªäž»ã¯èª°ã§ããïŒ
îBCPE Perseus Investor Ord Shs (Proposed)ã®äžäœ5åã®æ ªäž»ã¯ä»¥äžã®ãšããã§ããMr. Ronald C. (Ron) Renaud, Jr.